CANbridge gains its second cancer project through deal with EUSA
Executive Summary
CANbridge Life Sciences Ltd. gained its second cancer project, licensing exclusive rights to sell in China EUSA Pharma's Caphosol oral rinse.
Deal Industry
- Biotechnology
- Medical Devices
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice